Table 3

Pooled estimate of the association between obesity and COVID-19 outcomes in restricted (by age, sex, race/ethnicity, disease or condition) populations (n=40)

ExposureHospital admission+ICU+IMV*DeathStudies with combinations of outcomes†
BMI continuous (5 units)
 Studies (n)462
 Pooled OR (95% CI)1.16 (1.05 to 1.28)1.16 (1.05 to 1.34)1.69 (0.70 to 4.16)
Overweight versus normal weight
 Studies (n)553
 Pooled OR (95% CI)1.03 (0.90 to 1.17)1.01 (0.88 to 1.16)1.51 (0.89 to 2.58)
Obese versus normal weight
 Studies (n)552
 Pooled OR (95% CI)1.16 (0.92 to 1.45)1.03 (0.78 to 1.37)1.33 (0.99 to 1.80)
Obese versus non-obese
 Studies (n)698
 Pooled OR (95% CI)1.84 (1.43 to 2.37)1.88 (1.61 to 2.19)1.67 (1.29 to 2.15)
Extreme obese versus normal weight
 Studies (n)221
 Pooled OR (95% CI)1.33 (0.98 to 1.79)1.40 (1.13 to 1.72)1.22 (0.67 to 2.21)
Extreme obese versus non-obese
 Studies (n)001
 Pooled OR (95% CI)4.10 (1.28 to 13.11)
Non-BMI-defined obesity‡
 Studies (n)011
 Pooled OR (95% CI)10.71 (1.57 to 73.06)1.25 (0.98 to 1.59)
  • *Pooled studies included in-hospital admission, ICU and IMV. The estimates for hospital admission, ICU and IMV were not shown separately because of low number of studies.

  • †Studies whose endpoint was the combination of two or more of the following: hospital admission, ICU, IMV, death or other conditions pertaining to a severe disease.

  • ‡Non-BMI-defined obesity includes neck circumference, waist circumference, waist-to-hip ratio and visceral adipose tissue.

  • BMI, body mass index; ICU, intensive care unit; IMV, invasive mechanical ventilation.